“[Budget Impact Analysis of Idarucizumab for the Management of Patients Treated With Dabigatran in Emergency Urgent Situations in Italy]”. 2016. Farmeconomia. Health Economics and Therapeutic Pathways 17 (2): 47-58. https://doi.org/10.7175/fe.v17i2.1243.